Figure S1 from Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer

Supplemental Figure 1. Key Biomarkers for KRAS mutation subtypes in adenocarcinoma and squamous cell NSCLC histologies. Frequency of the 10 most common co-occurring mutations including TP53, STK11, ATM, KEAP1, CDKN2A, U2AF1, BRAF, NFE3L2, RAF1 and EGFR are displayed for each KRAS mutation subtype in adenocarcinoma and squamous cell NSCLC cohorts.